Access to anti-retroviral drugs, female in Pakistan
Pakistan: Access to anti-retroviral drugs, female was 24.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Pakistan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Pakistan is 24.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 20.0% on the previous year and up 300.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Pakistan peaked at 24.0% in 2024 and was at its lowest, 0.0%, in 2000.
Pakistan ranks 136th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Pakistan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 2.0% | — |
| 2003 | 3.0% | +50.0% |
| 2004 | 3.0% | +0.0% |
| 2005 | 2.0% | -33.3% |
| 2006 | 2.0% | +0.0% |
| 2007 | 4.0% | +100.0% |
| 2008 | 4.0% | +0.0% |
| 2009 | 4.0% | +0.0% |
| 2010 | 4.0% | +0.0% |
| 2011 | 4.0% | +0.0% |
| 2012 | 6.0% | +50.0% |
| 2013 | 5.0% | -16.7% |
| 2014 | 6.0% | +20.0% |
| 2015 | 6.0% | +0.0% |
| 2016 | 7.0% | +16.7% |
| 2017 | 8.0% | +14.3% |
| 2018 | 10.0% | +25.0% |
| 2019 | 13.0% | +30.0% |
| 2020 | 13.0% | +0.0% |
| 2021 | 15.0% | +15.4% |
| 2022 | 17.0% | +13.3% |
| 2023 | 20.0% | +17.6% |
| 2024 | 24.0% | +20.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.4% | 0.0% | 4.0% | 10 |
| 2010s | 6.9% | 4.0% | 13.0% | 10 |
| 2020s | 17.8% | 13.0% | 24.0% | 5 |
Countries ranked near Pakistan
More gender data for Pakistan
- Child population (UN estimates and projections) 94,592 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.6113 % change on previous year (2030)
- Population 182,291 (2030)
- Working-age population (UN estimates and projections) 182,291 (2030)
- Population (UN estimates and projections), annual growth rate 2.23 % change on previous year (2030)
- Age population, age 00, female, interpolated 3.22 million (2025)
- Age population, age 00, male, interpolated 3.37 million (2025)
- Age population, age 01, female, interpolated 3.17 million (2025)
- Age population, age 01, male, interpolated 3.31 million (2025)
- Age population, age 02, female, interpolated 3.14 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Pakistan?
- Access to anti-retroviral drugs, female in Pakistan was 24.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Pakistan?
- The highest recorded value was 24.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Pakistan?
- The lowest recorded value was 0.0% in 2000.
- How does Pakistan rank for access to anti-retroviral drugs, female?
- Pakistan ranks 136th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Pakistan?
- Over the last ten years it is up 300.0%. The long-run trend across the full record is volatile.
- Where does this Pakistan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.